Home > Publications database > Reprogramming Stars #18: Engineering Cell Fates and Preventing Disease by Repressing Unwanted Plasticity-An Interview with Dr. Moritz Mall. > print |
001 | 294376 | ||
005 | 20241031182312.0 | ||
024 | 7 | _ | |a 10.1089/cell.2024.36789.mor |2 doi |
024 | 7 | _ | |a pmid:39475770 |2 pmid |
024 | 7 | _ | |a 2152-4971 |2 ISSN |
024 | 7 | _ | |a 2152-4998 |2 ISSN |
037 | _ | _ | |a DKFZ-2024-02209 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Mall, Moritz |0 P:(DE-He78)cb70d67b37a3b9239e352b7fbead37f5 |b 0 |e First author |u dkfz |
245 | _ | _ | |a Reprogramming Stars #18: Engineering Cell Fates and Preventing Disease by Repressing Unwanted Plasticity-An Interview with Dr. Moritz Mall. |
260 | _ | _ | |a New Rochelle, NY |c 2024 |b Liebert |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1730380813_24810 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #EA:A340# / DKFZ-ZMBH Alliance |
536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Lopes, Mariana |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Pereira, Carlos-Filipe |0 P:(DE-HGF)0 |b 2 |
773 | _ | _ | |a 10.1089/cell.2024.36789.mor |g Vol. 26, no. 5, p. 125 - 131 |0 PERI:(DE-600)2542484-1 |n 5 |p 125 - 131 |t Cellular reprogramming |v 26 |y 2024 |x 2152-4971 |
909 | C | O | |o oai:inrepo02.dkfz.de:294376 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)cb70d67b37a3b9239e352b7fbead37f5 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 1 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 2 |6 P:(DE-HGF)0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL REPROGRAM : 2022 |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-26 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-26 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-26 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2023-10-26 |
920 | 1 | _ | |0 I:(DE-He78)A340-20160331 |k A340 |l A340 NWG Engeneering von Zellidentitäten und Krankheitsmodellen |x 0 |
920 | 0 | _ | |0 I:(DE-He78)A340-20160331 |k A340 |l A340 NWG Engeneering von Zellidentitäten und Krankheitsmodellen |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)A340-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|